Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

Morning blood pressure tied to target-organ damage

Physicians should ask patients to take home blood pressure readings in the morning as well as the evening before making therapeutic decisions, say researchers.

3 Feb 2014

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced dosing of the first patients enrolled in the Company's Phase 2b study of PG324, a novel, fixed-combination of Aerie's AR-13324 and latanoprost, a prostaglandin analogue that is the most widely prescribed glaucoma drug.

31 Jan 2014

Psychiatrists urged to monitor metabolic changes in psychosis patients

Japanese psychiatrists are largely aware of the metabolic abnormalities that may arise from antipsychotic treatment, but most do not monitor their patients sufficiently, research shows.

30 Jan 2014

Single-pill combination antihypertensives have mixed adherence effects

Switching to single-pill combination antihypertensives results in marked improvements in medication adherence, except for in a subset of patients for whom the strategy may backfire, say researchers.

27 Jan 2014

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

The Myelin Repair Foundation today announced it has entered a Cooperative Research and Development Agreement with the National Institutes of Health to assess MRF-008, as a potential therapeutic for multiple sclerosis. This CRADA will facilitate collaboration between the MRF and National Institute of Neurological Disorders and Stroke at the NIH Clinical Center to study MRF-008, a drug identified by the MRF as a potential neuroprotective therapeutic to enhance repair in multiple sclerosis patients.

27 Jan 2014

Morbidity following liver transplant is highest among obese patients with diabetes

Researchers from New Zealand report that morbidity following liver transplant is highest among obese patients with diabetes, but these risk factors do not influence post-transplant survival.

24 Jan 2014

Research under way to develop new techniques for detecting diabetic retinopathy

Research is under way to develop new techniques for detecting diabetic retinopathy at early onset with the hope of improving prevention and treatment of this major cause of blindness.

22 Jan 2014

Clues of "silent thief of sight”: Glaucoma

Glaucoma is sometimes called the "silent thief of sight" because it slowly damages the eyes and can cause irreparable harm before there is any vision loss. But this disease is stealthy in more ways than one.

22 Jan 2014

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.

21 Jan 2014

Home blood pressure best guide to metabolic risk

Home blood pressure is a good guide to which patients are likely to have the metabolic syndrome, say researchers.

20 Jan 2014

Higher vitamin D levels linked with better cognition and less depression in PD patients

A new study exploring vitamin D levels in patients with Parkinson's disease (PD) opens up the possibility of a new avenue of early intervention that may delay or prevent the onset of cognitive impairment and depression. The findings are published in the Journal of Parkinson's Disease.

16 Jan 2014

Joslin Diabetes Center launches pilot program with Truman Medical Centers to test JCAT

Joslin Diabetes Center, an affiliate of Harvard Medical School, has launched a pilot program in conjunction with Truman Medical Centers, the primary teaching hospital for the University of Missouri-Kansas City Schools of Medicine to test the capabilities of a novel and innovative care analytics tool called the Joslin Clinical Analytical Tool (JCAT™).

15 Jan 2014

Obesity interferes with blood pressure control

Patients who are overweight or obese have a high risk for uncontrolled blood pressure, despite often taking multiple antihypertensive agents, say researchers.

13 Jan 2014

Cardiovascular conditions may be overlooked in bipolar disorder

Cardiovascular comorbidities may be going under-recognized and undertreated in patients with bipolar disorder, say UK researchers.

10 Jan 2014

New study compares blood pressure management in the US and England

In the US but not in England, patients on low incomes with high blood pressure have their condition managed poorly compared with those who earn more.

9 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

More standardised methods needed for extemporaneous preparation of paediatric medicines

More standardised methods are needed for the extemporaneous preparation of paediatric medicines, indicates a doctoral dissertation examined at the University of Eastern Finland. Hospital pharmacies modify adult medicines for children when there are no suitable paediatric medicines available. Medicines intended for adults can be modified for children into oral suspensions, oral powders or capsules the contents of which are emptied for use.

9 Jan 2014

Study finds discrepancies in prevalence estimates of mental disorders in middle-aged and older adults

Common methods of assessing mental or physical disorders may consistently underestimate the prevalence of mental disorders among middle-aged and older adults, a new study from the Johns Hopkins Bloomberg School of Public Health has found.

9 Jan 2014

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.

9 Jan 2014

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced it has received CE mark approval for its Vado Steerable Introducer Sheath for vascular and intracardiac access including Atrial Fibrillation procedures.

8 Jan 2014

Hypertension (High Blood Pressure) News and Research

Further Reading

Morning blood pressure tied to target-organ damage

Aerie Pharmaceuticals announces dosing of first patients in PG324 Phase 2b study

Psychiatrists urged to monitor metabolic changes in psychosis patients

Single-pill combination antihypertensives have mixed adherence effects

Myelin Repair Foundation enters into agreement with NIH to assess MRF-008 for multiple sclerosis

Morbidity following liver transplant is highest among obese patients with diabetes

Research under way to develop new techniques for detecting diabetic retinopathy

Clues of "silent thief of sight”: Glaucoma

Forest Laboratories third quarter net sales increase 24.9% to $846.8 million

Home blood pressure best guide to metabolic risk

Higher vitamin D levels linked with better cognition and less depression in PD patients

Joslin Diabetes Center launches pilot program with Truman Medical Centers to test JCAT

Obesity interferes with blood pressure control

Cardiovascular conditions may be overlooked in bipolar disorder

New study compares blood pressure management in the US and England

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

More standardised methods needed for extemporaneous preparation of paediatric medicines

Study finds discrepancies in prevalence estimates of mental disorders in middle-aged and older adults

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Kalila Medical receives CE mark approval for Vado Steerable Introducer Sheath

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News